Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Combining platelet-rich plasma and minoxidil can effectively regrow hair in severe alopecia areata cases.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

An intelligent system can classify hair follicles and measure hair loss severity with reasonable accuracy.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

A vitamin and mineral supplement significantly reduced hair shedding in Brazilian women with telogen effluvium.

Certain scalp tissue features can predict how well alopecia areata responds to steroid injections.

Trichoscopy can effectively tell apart tinea capitis and alopecia areata in children by looking for specific hair shapes.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Mesalazine may help treat extensive alopecia areata effectively.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Caffeine shows promise for treating some types of hair loss, but more research is needed.